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MDiscussion
Dr Olaf Reinhartz (Stanford, Calif). Thank you. Dr Crow, you
and your group are to be commended for trying to shed light on a
subject that still remains quite nebulous to us. The benefits of
perioperative steroids for complex congenital repairs are still
unclear, and, as of late, as you mentioned, there is even evidence
that steroids might actually be harmful at least in some patients.
Practice between institutions varies as widely as one would
imagine.
Your study is carried out well and has 3 important findings.
Number one, blood drug levels despite consistent drug dosage
are highly variable, and this variation is not easily explained by
patient factors like age, complexity of the procedure, etcetera.
Secondly, expectedly and logically higher drug levels lead to
more and longer adrenal suppression. And, third, cytokine levels
are not different between high and low drug levels in your
2 groups.
I have 2 questions for you. I will ask them one at a time. The first
one relates to the large drug level variability. I cannot come up with
an explanation why there would be 2 distinct groups as you are
describing them, high versus low dexamethasone levels in your
study. Did you just arbitrarily categorize these patients into 2
groups? I did not see a scattergram to facilitate analysis. Or, do
you really think there are 2 distinct patient populations and you
just have not found out yet what distinguishes them?
Dr Crow. Yes, it is an excellent question. We did not have 2
distinct groups. They were scattered around this 15 mg/dL mark
that I chose, and I just tried to find a point that looked like most
of the group fell above or below in order to make some
comparisons.The Journal of Thoracic and CaThere is a wide range of variability, but there does appear to be
significant differences between the 2 groups. If you divide on that
15 mark, the groups are significantly different between their levels
at each point in time.
We do have some studies in methylprednisolone in adults that
demonstrate that there is a large variety of components that could
contribute to this. And there have even been some studies by Joe
Carcillo that show that even in healthy children, we will have
differences in drug metabolism.
So inflammatory markers also play into drug metabolism,
and IL-6 specifically has been shown to decrease clearance
with the cytochrome P450 system, which is utilized to clear
dexamethasone.
We did not find a difference in IL-6 levels in our population that
would have explained that, but I think it just highlights that there
are many, many questions that still need to be investigated to try
to figure out why there is such discrepant levels in these patients.
Dr Reinhartz. Secondly, you and others before you have
proposed larger prospective multicenter trials around this topic.
How would you design these trials? What should the treatment
arms be, particularly in light of the more recent data that you
mentioned questioning the benefit of perioperative steroids
entirely?
Dr Crow. I love this question because I think it is really where
the field needs to go now. I think especially with the latest large
studies showing potential negative outcomes of corticosteroid
treatment. As a result, the clinical equipoise around the practice
has grown even in the last 5 years. I am amazed at how much
more willing people are to consider not giving corticosteroids
intraoperatively. There are now centers that do not give
corticosteroids and centers that do give.
So I do think that while we still have some challenges to get
people to buy into a randomized clinical trial, which would be
the gold standard, there is a possibility to design a study where
we take different centers that have different steroid practices,
measure these blood levels in those patients in a larger sample,
and try to figure out is the best strategy. Are there drug levels
that can suppress the components we need to suppress, and will
not suppress things like the immune system that are needed to
prevent infection?
We have just completed analysis on samples from an additional
center, and so we will have the opportunity to look at patients at 2
different centers and have preliminary data to pursue that kind of
multicenter investigation. In this scenario, people could still use
their standard practices, but we could monitor how those practices
translate into postoperative inflammatory/stress responses and try
to draw some conclusions from that information.
Dr James S. Tweddell (Milwaukee, Wis). That was a really
very interesting study and an excellent presentation. I have just a
couple of questions.
How far in advance of skin incision or initiation of bypass were
the steroids given?
Dr Crow. Steroids are usually given immediately after the
patients are asleep and then right before the bypass prime.
Sowe had about an hour time period. I actually went and looked
at each of them individually, and for all the patients they got
0.5 mg/kg of dexamethasone right after induction and then another
0.5 mg/kg right before bypass was starting. And that was therdiovascular Surgery c Volume 147, Number 1 481
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Mstandard protocol for all the patients. This time period was about
an hour for each patient.
Dr Tweddell.Did you look at any variability in that interval be-
tween the first dose and the second dose? Did that have an impact?
Dr Crow. So we actually did not have very much variability.
Outside of about 20 minutes, the intervals between those steroids
were very similar. You could also question variability in the time
between steroid administration and ICU arrival, since we use the
level at ICU arrival to divide the patients into 2 groups. There
was variability between when bypass started and when it would
have finished, and when the patient arrived to the ICU. In an
attempt to control for this variability, we compared bypass times
between groups. That is sort of a surrogate marker of how long
the operative time is for these patients. There were no significant
differences in bypass time between groups.
But, again, this is another area where it would be nice to have a
larger patient population where you could look a little more
discretely at some of those variables. Twenty minutes might end
up being significant if you had enough patients to look at it in.
Dr Tweddell. Is there any potential to go back and look at the
ACTH levels in these patients?
Dr Crow. Yes. I can actually show it to you right now.
Dr Tweddell. I’m glad I asked a question you are prepared for.
Dr Crow. Well, I did not have time to put it in. Otherwise,
I would have shown you that, too.
But the ACTH levels were quite similar to the cortisol levels,
and they were similarly suppressed, as you can see, in that high
dexamethasone group.482 The Journal of Thoracic and Cardiovascular SurgSo, it looks like we suppressed the entire axis. And, in fact,
dexamethasone is a more potent suppressor of the stress response
than your innate cortisol levels. So when I show that negative
feedback loop, our cortisol does not suppress the hypothalamus
pituitary as much as dexamethasone does.
So, we are really playing with a pretty powerful mediator. And
we know the genomic effects of dexamethasone work through
transcription and translation and will actually produce a much
more prolonged effect on adrenal suppression even after the blood
levels have cleared.
So, I think it is very interesting that we have that time period
where we are no longer supplementing. Cortisol levels are low
and ACTH levels are low, lower even than when the patient first
came to surgery.
I am looking forward to looking closer at that 8- and 24-hour
time period and beyond to see if we can actually pick out patients
that are more labile during that time or kind of seem to be doing
okay and then get worse. Is that part of the problem—that we
have created this iatrogenic adrenal insufficiency?
Dr Lyle D. Joyce (Rochester, Minn). Dr Crow, I assume you
would be happy to have any centers here that are interested in
joining you to contact you, right?
Dr Crow. Yes. That would be great.
Dr Joyce. Because, as you say, there is variability across the
country, and it would be nice to sort that out.
Dr Crow. Yes. The key to answering this question will
definitely be multicenter evaluation of what we are already
doing.ery c January 2014
